STOCK TITAN

Kymera Therapeutics Inc - KYMR STOCK NEWS

Welcome to our dedicated news page for Kymera Therapeutics (Ticker: KYMR), a resource for investors and traders seeking the latest updates and insights on Kymera Therapeutics.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Kymera Therapeutics's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Kymera Therapeutics's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
clinical trial
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.3%
Tags
clinical trial
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-15.08%
Tags
earnings
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.67%
Tags
conferences earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.2%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.17%
Tags
earnings
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.11%
Tags
conferences earnings
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.81%
Tags
partnership
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.14%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.78%
Tags
management
Kymera Therapeutics Inc

Nasdaq:KYMR

KYMR Rankings

KYMR Stock Data

2.46B
40.08M
1.38%
102.55%
13.63%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
US
Watertown

About KYMR

kymera therapeutics is pioneering a transformative new approach to treating previously untreatable diseases. we are advancing the field of targeted protein degradation, accessing the body’s innate protein recycling machinery to degrade rather than inhibit dysregulated, disease-causing proteins. powered by a proprietary predictive modeling capability and a game-changing integrated degradation platform with a novel small molecule modality, our company is committed to accelerating drug discovery with an unmatched ability to target and degrade the most intractable of proteins, and advance new treatment options for patients. learn more at kymeratx.com.